Ani Pharmaceuticals Inc (ANIP)
R&D Expense Growth
15.89%
Fiscal year · Period ending:
ANIP R&D Expense Growth
Latest reported15.89%period ending
Latest reported15.89%period ending
ANIP FY R&D Growth (YoY) (0.00% → 15.89%)
Latest values, visible window
High-resolution chart · PNG
ANIP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 15.8879% | |
| 30.0268% | |
| 53.6249% | |
| 96.3057% | |
| -28.9482% | |
| -19.2114% | |
| 28.7107% | |
| 69.6582% | |
| 212.1129% | |
| 1.1134% | |
| 7.3189% | |
| 56.4252% | |
| -89.8631% | |
| -61.7746% | |
| 11.2749% | |
| 190.2327% | |
| -13.3591% | |
| 232.3288% | |
| 23.2296% | |
| -39.8407% | |
| -30.0505% | |
| 148.2091% | |
| -22.8836% | |
| 123.4801% | |
| 13.4605% | |
| 185.7805% | |
| -52.8195% | |
| 0% |